How DNA-Driven Prescriptions Could Save the NHS over £530M Annually
Published 27/03/2025
Every year, adverse drug reactions (ADRs) account for 6.5% of hospital admissions in the UK, costing the NHS an estimated £530 million annually. These preventable incidents burden an already overstretched healthcare system and impact patients' lives with prolonged recovery times and unnecessary suffering. But, what if there were a way to eliminate this trial-and-error approach to prescribing? Enter pharmacogenomics: the future of personalised medicine.
